Skip to main content
Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
5.02
+0.12 (2.45%)
Jun 6, 2025, 4:10 PM AEST

Mayne Pharma Group Revenue

Mayne Pharma Group had revenue of 213.05M AUD in the half year ending December 31, 2024, with 307.91% growth. This brings the company's revenue in the last twelve months to 413.53M, up 64.47% year-over-year. In the fiscal year ending June 30, 2024, Mayne Pharma Group had annual revenue of 388.40M with 111.56% growth.

Revenue (ttm)
413.53M
Revenue Growth
+64.47%
P/S Ratio
0.96
Revenue / Employee
427.64K
Employees
967
Market Cap
398.10M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2024388.40M204.81M111.56%
Jun 30, 2023183.59M26.44M16.82%
Jun 30, 2022157.15M-243.63M-60.79%
Jun 30, 2021400.78M-56.20M-12.30%
Jun 30, 2020456.99M-68.22M-12.99%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 24.61B
Pro Medicus 184.58M
Cochlear 2.31B
Sonic Healthcare 9.33B
Telix Pharmaceuticals 783.21M
Ramsay Health Care 17.12B
Ansell 3.00B
Regis Healthcare 1.10B
Revenue Rankings

Mayne Pharma Group News

More News